Literature DB >> 29464407

Somatostatin and diabetic retinopathy: an evolving story.

Olga Simó-Servat1,2, Cristina Hernández1,2, Rafael Simó3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29464407     DOI： 10.1007/s12020-018-1561-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  24 in total

1.  Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project.

Authors:  Ana Rita Santos; Luísa Ribeiro; Francesco Bandello; Rosangela Lattanzio; Catherine Egan; Ulrik Frydkjaer-Olsen; José García-Arumí; Jonathan Gibson; Jakob Grauslund; Simon P Harding; Gabriele E Lang; Pascale Massin; Edoardo Midena; Peter Scanlon; Stephen J Aldington; Sílvia Simão; Christian Schwartz; Berta Ponsati; Massimo Porta; Miguel Ângelo Costa; Cristina Hernández; José Cunha-Vaz; Rafael Simó
Journal:  Diabetes       Date:  2017-06-29       Impact factor: 9.461

2.  Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.

Authors:  Cristina Hernández; Patricia Bogdanov; Lidia Corraliza; Marta García-Ramírez; Cristina Solà-Adell; José A Arranz; Ana I Arroba; Angela M Valverde; Rafael Simó
Journal:  Diabetes       Date:  2015-09-17       Impact factor: 9.461

3.  Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial.

Authors:  Marina Trento; Olga Durando; Sonia Lavecchia; Lorena Charrier; Franco Cavallo; Miguel Angelo Costa; Cristina Hernández; Rafael Simó; Massimo Porta
Journal:  Endocrine       Date:  2016-09-14       Impact factor: 3.633

4.  Diabetes mellitus and sexual ateliotic dwarfism: a comparative study.

Authors:  T J Merimee; S E Fineberg; V A McKusick; J Hall
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

5.  Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?

Authors:  Q Wang; D G Dills; R Klein; B E Klein; S E Moss
Journal:  Diabetes       Date:  1995-02       Impact factor: 9.461

Review 6.  Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

Authors:  Rafael Simó; Esther Carrasco; Marta García-Ramírez; Cristina Hernández
Journal:  Curr Diabetes Rev       Date:  2006-02

Review 7.  Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives.

Authors:  Cristina Hernández; Olga Simó-Servat; Rafael Simó
Journal:  Endocrine       Date:  2014-03-14       Impact factor: 3.633

8.  Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy.

Authors:  P S Sharp; T J Fallon; O J Brazier; L Sandler; G F Joplin; E M Kohner
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

9.  Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study.

Authors:  Jack R W Brownrigg; Cian O Hughes; David Burleigh; Alan Karthikesalingam; Benjamin O Patterson; Peter J Holt; Matthew M Thompson; Simon de Lusignan; Kausik K Ray; Robert J Hinchliffe
Journal:  Lancet Diabetes Endocrinol       Date:  2016-05-20       Impact factor: 32.069

10.  Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.

Authors:  Cristina Hernández; Marta García-Ramírez; Lidia Corraliza; Jimena Fernández-Carneado; Josep Farrera-Sinfreu; Berta Ponsati; Agueda González-Rodríguez; Angela M Valverde; Rafael Simó
Journal:  Diabetes       Date:  2013-03-08       Impact factor: 9.461
View more
  4 in total

1.  Advanced proliferative diabetic retinopathy and macular edema in acromegaly: a case report and literature review.

Authors:  Akiko Yuno; Akemi Ikota; Shigeki Koizumi; Yasuo Mashio; Hiroko Imaizumi; Yutaka Sawamura; Akira Shimatsu
Journal:  Diabetol Int       Date:  2022-01-25

Review 2.  Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation.

Authors:  Ricardo Raúl Robles-Rivera; José Alberto Castellanos-González; Cecilia Olvera-Montaño; Raúl Alonso Flores-Martin; Ana Karen López-Contreras; Diana Esperanza Arevalo-Simental; Ernesto Germán Cardona-Muñoz; Luis Miguel Roman-Pintos; Adolfo Daniel Rodríguez-Carrizalez
Journal:  Oxid Med Cell Longev       Date:  2020-03-11       Impact factor: 6.543

Review 3.  Recent developments of neuroprotective agents for degenerative retinal disorders.

Authors:  Kepeng Ou; Youjian Li; Ling Liu; Hua Li; Katherine Cox; Jiahui Wu; Jian Liu; Andrew D Dick
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

4.  Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy.

Authors:  Rosario Amato; Martina Giannaccini; Massimo Dal Monte; Maurizio Cammalleri; Alessandro Pini; Vittoria Raffa; Matteo Lulli; Giovanni Casini
Journal:  Front Bioeng Biotechnol       Date:  2020-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.